The EpiPen, a Case Study in Health System Dysfunction

Re:The EpiPen, a Case Study in Health System Dysfunction by GunboatDiplomat on Saturday August 27, 2016 @10:10AM (#12372407)

I think it would make more sense to simply have a government owned corporation who's sole purpose is to produce generic drugs on which the patent has expired.

[ Parent | on HN ]

Re:The EpiPen, a Case Study in Health System Dysfunction by maxerickson on Saturday August 27, 2016 @10:16AM (#12372426)

The market for drugs like that generally functions quite well. Like a cash price of ~$5 a month well.

(The dustup over Martin Shkreli raising the price of Daraprim only happened because there were very few users of the drug)

[ Parent | on HN ]

Re:The EpiPen, a Case Study in Health System Dysfunction by cheriot on Saturday August 27, 2016 @10:52AM (#12372579)

Some drugs, like the cure for Hepatitis C, need to be available more widely before the patent runs out. It's a cure and only people that can come up with $84,000 dollars.

[ Parent | on HN ]